perugu_vada Posted September 8, 2020 Report Posted September 8, 2020 https://www.cnn.com/2020/09/08/health/pfizer-biontech-vaccine-october-intl-grm/index.html Pfizer and BioNTech are confident they can have a vaccine against the novel coronavirus ready for regulatory approval by the middle of October or early November, BioNTech CEO and co-founder Ugur Sahin told CNN Tuesday. "It has an excellent profile and I consider this vaccine ... near perfect, and which has a near perfect profile," Sahin said in an exclusive interview with CNN. US drug giant Pfizer and German firm BioNTech say they plan to provide 100 million doses of their vaccine candidate, BNT162, by the end of the year, and up to 1.3 billion doses in 2021. Sahin claims antibody responses in both young adults and the elderly have proven to be strong so far, with minimal side-effects. "We don't see frequent fever. So only a minor proportion of participants in this trial have fever," Sahin said. "We see also much lower symptoms like headache or like feeling tired. And the symptoms that are observed with such vaccines are temporary, they are usually observed for one or two days and then are gone." Quote
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.